Mouwasat’s 2014 net profit up 19% to SAR 240.1 mln

20/01/2015 Argaam Exclusive

View other reports

Mouwasat Medical Services Company, which operates hospitals and medical centers, reported 2014 net profit of SAR 240.1 mln, a 19 percent increase compared to the last year.

Financials (M)

Item	2013	2014	Change‬
Revenues	902.24	903.79	0.2 %
Gross Income	455.80	417.17	(8.5 %)
Operating Income	222.25	233.17	4.9 %
Net Income	201.20	240.12	19.3 %
Average Shares	200.00	200.00	-
EPS (Riyals)	1.01	1.20	19.3 %

A net profit of SAR 50.7 mln was reported for Q4-2014 compared to SAR 72.0 mln for Q3.

The company attributed the increase of 2014’s net profit compared to the last year to the continual effective utilization of available resources, the continuous development of medical systems, launching new services and due to the decrease of non-controlling interest from Eastern Medical Services Co located in eastern province, the percentages of ownership in this subsidiary company is 51% by Mouwasat Medical Services and 49% of the equity by non-controlling interest, has not achieved expected revenue and due to the capital gains from sale and swapping of lands amounting to SAR 23.9 million.

Q4-2014’s net profit increase compared to the same period last year was attributed to the capital gain from swapping land owned by the company with a land owned by Ministry Of Justice nearby Mouwasat Hospital Dammam amounting to SAR 2.3 million, and due to the decrease of non-controlling interest from Eastern Medical Services Co located in eastern province, the percentages of ownership of this subsidiary company 51% by Mouwasat Medical Services and 49% of the equity by non-controlling interest, has not achieved expected revenue. The decrease of the gross profits and operating income for the current quarter

compared to the same quarter of the previous year due to the inability of Mouwasat hospital Qatif which owned by Eastern Medical Services Company to achieve the expected operating results during the quarter, and also due to the negative results from operations of Mouwasat Hospital Riyadh which commenced its operations, Nov. 29, 2014 amounting to SAR 3.6 million.

Q4-2014’s net profit decline compared to Q3-2014 was attributed to:

1. Previous quarter net profit included capital gains of SAR 21.7 million as a result of sale of land was owned in Dhahran.

2. The negative results from operations of Mouwasat Hospital-Riyadh which commenced its operations, Nov. 29, 2014 amounting to SAR 3.6 million.

The decline of operating income for the current quarter compared to the previous quarter due to negative results from operation of Mouwasat Hospital-Riyadh which commenced its operations, Nov. 29, 2014 amounting to SAR 3.6 million.

Current Quarter Comparison (M)

Compared With The

Item	Q4 2013	Q4 2014	Change‬
Revenues	242.64	247.18	1.9 %
Gross Income	124.17	117.49	(5.4 %)
Operating Income	55.21	52.86	(4.3 %)
Net Income	50.42	50.75	0.7 %
Average Shares	200.00	200.00	-
EPS (Riyals)	0.25	0.25	0.7 %

Item	Q3 2014	Q4 2014	Change‬
Revenues	230.47	247.18	7.2 %
Gross Income	113.02	117.49	4.0 %
Operating Income	54.13	52.86	(2.3 %)
Net Income	71.99	50.75	(29.5 %)
Average Shares	200.00	200.00	-
EPS (Riyals)	0.36	0.25	(29.5 %)

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
Q1 2005	-	-	-	-	-	-
Q2 2005	-	-	-	-	-	-
Q3 2005	-	-	-	-	-	-
Q4 2005	-	-	-	-	-	-
2005	267.39	-	108.50	-	56.88	-
Q1 2006	-	-	-	-	-	-
Q2 2006	-	-	-	-	-	-
Q3 2006	-	-	-	-	-	-
Q4 2006	-	-	-	-	-	-
2006	342.93	28.3 %	135.46	24.8 %	62.36	9.6 %
Q1 2007	-	-	-	-	-	-
Q2 2007	-	-	-	-	-	-
Q3 2007	-	-	-	-	-	-
Q4 2007	-	-	-	-	-	-
2007	400.67	16.8 %	173.39	28.0 %	96.18	54.2 %
Q1 2008	113.83	-	52.37	-	27.91	-
Q2 2008	118.48	-	53.79	-	29.33	-
Q3 2008	104.92	-	47.23	-	23.73	-
Q4 2008	117.32	-	47.51	-	29.27	-
2008	454.55	13.4 %	200.90	15.9 %	110.24	14.6 %
Q1 2009	124.60	9.5 %	56.25	7.4 %	30.77	10.2 %
Q2 2009	140.62	18.7 %	67.77	26.0 %	41.29	40.8 %
Q3 2009	115.21	9.8 %	54.05	14.4 %	29.09	22.6 %
Q4 2009	137.16	16.9 %	49.94	5.1 %	20.05	(31.5 %)
2009	517.60	13.9 %	228.00	13.5 %	121.20	9.9 %
Q1 2010	143.79	15.4 %	68.04	21.0 %	39.35	27.9 %
Q2 2010	148.78	5.8 %	71.36	5.3 %	41.41	0.3 %
Q3 2010	134.72	16.9 %	63.30	17.1 %	29.14	0.2 %
Q4 2010	160.20	16.8 %	74.36	48.9 %	32.98	64.5 %
2010	587.49	13.5 %	277.05	21.5 %	142.87	17.9 %
Q1 2011	166.82	16.0 %	84.05	23.5 %	45.72	16.2 %
Q2 2011	164.93	10.9 %	76.76	7.6 %	41.80	0.9 %
Q3 2011	156.92	16.5 %	74.10	17.1 %	39.80	36.6 %
Q4 2011	189.77	18.5 %	89.09	19.8 %	41.95	27.2 %
2011	678.44	15.5 %	324.00	16.9 %	169.26	18.5 %
Q1 2012	195.57	17.2 %	94.32	12.2 %	53.36	16.7 %
Q2 2012	200.62	21.6 %	93.28	21.5 %	51.87	24.1 %
Q3 2012	187.28	19.3 %	84.01	13.4 %	37.08	(6.8 %)
Q4 2012	213.04	12.3 %	101.10	13.5 %	43.73	4.3 %
2012	796.51	17.4 %	372.71	15.0 %	186.04	9.9 %
Q1 2013	219.23	12.1 %	110.39	17.0 %	58.25	9.2 %
Q2 2013	228.74	14.0 %	116.90	25.3 %	59.96	15.6 %
Q3 2013	211.63	13.0 %	104.34	24.2 %	48.82	31.7 %
Q4 2013	242.64	13.9 %	124.17	22.8 %	55.21	26.3 %
2013	902.24	13.3 %	455.80	22.3 %	222.25	19.5 %
Q1 2014	243.54	11.1 %	124.18	12.5 %	62.97	8.1 %
Q2 2014	244.25	6.8 %	124.14	6.2 %	63.22	5.4 %
Q3 2014	230.47	8.9 %	113.02	8.3 %	54.13	10.9 %
Q4 2014	247.18	1.9 %	117.49	(5.4 %)	52.86	(4.3 %)
2014	903.79	0.2 %	417.17	(8.5 %)	233.17	4.9 %

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2005	267.39	-	108.50	-	56.88	-
2006	342.93	28.3 %	135.46	24.8 %	62.36	9.6 %
2007	400.67	16.8 %	173.39	28.0 %	96.18	54.2 %
2008	454.55	13.4 %	200.90	15.9 %	110.24	14.6 %
2009	517.60	13.9 %	228.00	13.5 %	121.20	9.9 %
2010	587.49	13.5 %	277.05	21.5 %	142.87	17.9 %
2011	678.44	15.5 %	324.00	16.9 %	169.26	18.5 %
2012	796.51	17.4 %	372.71	15.0 %	186.04	9.9 %
2013	902.24	13.3 %	455.80	22.3 %	222.25	19.5 %
2014	903.79	0.2 %	417.17	(8.5 %)	233.17	4.9 %

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
Q1 2005	-	-	-	-	-	-
Q2 2005	-	-	-	-	-	-
Q3 2005	-	-	-	-	-	-
Q4 2005	-	-	-	-	-	-
2005	53.65	-	0.27	-	53.65	0.27
Q1 2006	-	-	-	-	-	-
Q2 2006	-	-	-	-	-	-
Q3 2006	-	-	-	-	-	-
Q4 2006	-	-	-	-	-	-
2006	63.23	17.9 %	0.32	-	63.23	0.32
Q1 2007	-	-	-	-	-	-
Q2 2007	-	-	-	-	-	-
Q3 2007	-	-	-	-	-	-
Q4 2007	-	-	-	-	-	-
2007	88.76	40.4 %	0.44	-	88.76	0.44
Q1 2008	25.90	-	0.13	-	25.90	0.13
Q2 2008	26.63	-	0.13	-	26.63	0.13
Q3 2008	20.47	-	0.10	-	20.47	0.10
Q4 2008	24.07	-	0.12	-	24.07	0.12
2008	97.07	9.4 %	0.49	-	97.07	0.49
Q1 2009	26.55	2.5 %	0.13	-	26.55	0.13
Q2 2009	34.03	27.8 %	0.17	-	34.03	0.17
Q3 2009	21.88	6.9 %	0.11	-	21.88	0.11
Q4 2009	24.58	2.1 %	0.12	-	24.58	0.12
2009	107.04	10.3 %	0.54	-	107.04	0.54
Q1 2010	32.37	21.9 %	0.16	-	32.37	0.16
Q2 2010	34.77	2.2 %	0.17	-	34.77	0.17
Q3 2010	23.14	5.8 %	0.12	-	23.14	0.12
Q4 2010	28.28	15.1 %	0.14	-	28.28	0.14
2010	118.57	10.8 %	0.59	-	118.57	0.59
Q1 2011	39.14	20.9 %	0.20	-	39.14	0.20
Q2 2011	40.49	16.4 %	0.20	-	40.49	0.20
Q3 2011	33.71	45.7 %	0.17	-	33.71	0.17
Q4 2011	34.72	22.8 %	0.17	-	34.72	0.17
2011	148.06	24.9 %	0.74	-	148.06	0.74
Q1 2012	46.34	18.4 %	0.23	-	46.34	0.23
Q2 2012	47.26	16.7 %	0.24	-	47.26	0.24
Q3 2012	35.44	5.1 %	0.18	-	35.44	0.18
Q4 2012	42.56	22.6 %	0.21	-	42.56	0.21
2012	171.60	15.9 %	0.86	-	171.60	0.86
Q1 2013	52.52	13.3 %	0.26	-	52.52	0.26
Q2 2013	54.16	14.6 %	0.27	-	54.16	0.27
Q3 2013	44.11	24.5 %	0.22	-	44.11	0.22
Q4 2013	50.42	18.4 %	0.25	-	50.42	0.25
2013	201.20	17.3 %	1.01	-	201.20	1.01
Q1 2014	57.94	10.3 %	0.29	-	57.94	0.29
Q2 2014	59.44	9.8 %	0.30	-	59.44	0.30
Q3 2014	71.99	63.2 %	0.36	21.70	50.29	0.25
Q4 2014	50.75	0.7 %	0.25	2.20	48.55	0.24
2014	240.12	19.3 %	1.20	23.90	216.22	1.08

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
2005	53.65	-	0.27	-	53.65	0.27
2006	63.23	17.9 %	0.32	-	63.23	0.32
2007	88.76	40.4 %	0.44	-	88.76	0.44
2008	97.07	9.4 %	0.49	-	97.07	0.49
2009	107.04	10.3 %	0.54	-	107.04	0.54
2010	118.57	10.8 %	0.59	-	118.57	0.59
2011	148.06	24.9 %	0.74	-	148.06	0.74
2012	171.60	15.9 %	0.86	-	171.60	0.86
2013	201.20	17.3 %	1.01	-	201.20	1.01
2014	240.12	19.3 %	1.20	23.90	216.22	1.08

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2005	-	-	-
Q2 2005	-	-	-
Q3 2005	-	-	-
Q4 2005	-	-	-
2005	40.58 %	28.06 %	20.06 %
Q1 2006	-	-	-
Q2 2006	-	-	-
Q3 2006	-	-	-
Q4 2006	-	-	-
2006	39.50 %	26.05 %	18.44 %
Q1 2007	-	-	-
Q2 2007	-	-	-
Q3 2007	-	-	-
Q4 2007	-	-	-
2007	43.28 %	31.24 %	22.15 %
Q1 2008	-	-	-
Q2 2008	-	-	-
Q3 2008	-	-	-
Q4 2008	44.20 %	30.76 %	21.36 %
2008	44.20 %	30.76 %	21.36 %
Q1 2009	44.01 %	30.89 %	21.00 %
Q2 2009	44.88 %	32.07 %	21.57 %
Q3 2009	45.32 %	32.67 %	21.40 %
Q4 2009	44.05 %	30.06 %	20.68 %
2009	44.05 %	30.06 %	20.68 %
Q1 2010	44.67 %	30.72 %	21.03 %
Q2 2010	44.66 %	30.02 %	20.85 %
Q3 2010	44.76 %	28.94 %	20.35 %
Q4 2010	47.16 %	30.15 %	20.18 %
2010	47.16 %	30.15 %	20.18 %
Q1 2011	48.00 %	29.97 %	20.53 %
Q2 2011	47.63 %	29.54 %	20.91 %
Q3 2011	47.66 %	30.31 %	21.83 %
Q4 2011	47.76 %	30.40 %	21.82 %
2011	47.76 %	30.40 %	21.82 %
Q1 2012	47.27 %	30.32 %	21.95 %
Q2 2012	47.22 %	30.30 %	21.81 %
Q3 2012	46.65 %	28.88 %	21.18 %
Q4 2012	46.79 %	28.28 %	21.54 %
2012	46.79 %	28.28 %	21.54 %
Q1 2013	47.40 %	28.13 %	21.68 %
Q2 2013	48.62 %	28.20 %	21.77 %
Q3 2013	49.59 %	28.72 %	22.16 %
Q4 2013	50.52 %	29.11 %	22.30 %
2013	50.52 %	29.11 %	22.30 %
Q1 2014	50.68 %	28.86 %	22.30 %
Q2 2014	50.62 %	28.77 %	22.49 %
Q3 2014	50.53 %	28.82 %	22.70 %
Q4 2014	49.60 %	28.54 %	22.40 %
2014	46.16 %	30.49 %	23.92 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2005	40.58 %	28.06 %	20.06 %
2006	39.50 %	26.05 %	18.44 %
2007	43.28 %	31.24 %	22.15 %
2008	44.20 %	30.76 %	21.36 %
2009	44.05 %	30.06 %	20.68 %
2010	47.16 %	30.15 %	20.18 %
2011	47.76 %	30.40 %	21.82 %
2012	46.79 %	28.28 %	21.54 %
2013	50.52 %	29.11 %	22.30 %
2014	46.16 %	30.49 %	23.92 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2005	-	-	-
Q2 2005	-	-	-
Q3 2005	-	-	-
Q4 2005	-	-	-
Q1 2006	-	-	-
Q2 2006	-	-	-
Q3 2006	-	-	-
Q4 2006	-	-	-
Q1 2007	-	-	-
Q2 2007	-	-	-
Q3 2007	-	-	-
Q4 2007	-	-	-
Q1 2008	46.01 %	31.17 %	22.75 %
Q2 2008	45.40 %	31.49 %	22.48 %
Q3 2008	45.02 %	29.90 %	19.51 %
Q4 2008	40.49 %	30.38 %	20.52 %
Q1 2009	45.14 %	31.63 %	21.31 %
Q2 2009	48.19 %	35.49 %	24.20 %
Q3 2009	46.91 %	32.66 %	18.99 %
Q4 2009	36.41 %	20.87 %	17.92 %
Q1 2010	47.32 %	33.89 %	22.51 %
Q2 2010	47.96 %	32.68 %	23.37 %
Q3 2010	46.98 %	27.76 %	17.18 %
Q4 2010	46.42 %	26.45 %	17.65 %
Q1 2011	50.38 %	32.72 %	23.46 %
Q2 2011	46.54 %	30.78 %	24.55 %
Q3 2011	47.22 %	31.20 %	21.48 %
Q4 2011	46.95 %	27.37 %	18.29 %
Q1 2012	48.23 %	32.08 %	23.69 %
Q2 2012	46.49 %	30.64 %	23.56 %
Q3 2012	44.86 %	25.18 %	18.92 %
Q4 2012	47.46 %	25.28 %	19.98 %
Q1 2013	50.35 %	31.12 %	23.96 %
Q2 2013	51.11 %	30.61 %	23.68 %
Q3 2013	49.30 %	27.68 %	20.84 %
Q4 2013	51.18 %	27.14 %	20.78 %
Q1 2014	50.99 %	29.94 %	23.79 %
Q2 2014	50.83 %	30.16 %	24.34 %
Q3 2014	49.04 %	27.98 %	21.82 %
Q4 2014	47.53 %	26.09 %	19.64 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2005	-	-	-	-
Q2 2005	-	-	-	-
Q3 2005	-	-	-	-
Q4 2005	-	-	-	-
Q1 2006	-	-	-	-
Q2 2006	-	-	-	-
Q3 2006	-	-	-	-
Q4 2006	-	-	-	-
Q1 2007	-	-	-	-
Q2 2007	-	-	-	-
Q3 2007	-	-	-	-
Q4 2007	-	-	-	-
Q1 2008	200.00	-	-	1.90
Q2 2008	200.00	-	-	1.92
Q3 2008	200.00	-	-	2.02
Q4 2008	200.00	0.49	0.49	2.05
Q1 2009	200.00	0.49	0.49	2.18
Q2 2009	200.00	0.53	0.53	2.27
Q3 2009	200.00	0.53	0.53	2.28
Q4 2009	200.00	0.54	0.54	2.40
Q1 2010	200.00	0.56	0.56	2.56
Q2 2010	200.00	0.57	0.57	2.61
Q3 2010	200.00	0.57	0.57	2.72
Q4 2010	200.00	0.59	0.59	2.86
Q1 2011	200.00	0.63	0.63	3.06
Q2 2011	200.00	0.66	0.66	3.01
Q3 2011	200.00	0.71	0.71	3.18
Q4 2011	200.00	0.74	0.74	3.34
Q1 2012	200.00	0.78	0.78	3.57
Q2 2012	200.00	0.81	0.81	3.44
Q3 2012	200.00	0.82	0.82	3.61
Q4 2012	200.00	0.86	0.86	3.82
Q1 2013	200.00	0.89	0.89	4.08
Q2 2013	200.00	0.92	0.92	3.98
Q3 2013	200.00	0.97	0.97	4.20
Q4 2013	200.00	1.01	1.01	4.44
Q1 2014	200.00	1.03	1.03	4.73
Q2 2014	200.00	1.06	1.06	4.53
Q3 2014	200.00	1.20	1.09	4.89
Q4 2014	200.00	1.20	1.08	5.14

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2005	200.00	0.27	0.27	1.25
2006	200.00	0.32	0.32	1.49
2007	200.00	0.44	0.44	1.77
2008	200.00	0.49	0.49	2.05
2009	200.00	0.54	0.54	2.40
2010	200.00	0.59	0.59	2.86
2011	200.00	0.74	0.74	3.34
2012	200.00	0.86	0.86	3.82
2013	200.00	1.01	1.01	4.44
2014	200.00	1.20	1.08	5.14

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2005	-	-	-
Q2 2005	-	-	-
Q3 2005	-	-	-
Q4 2005	-	-	-
Q1 2006	-	-	-
Q2 2006	-	-	-
Q3 2006	-	-	-
Q4 2006	-	-	-
Q1 2007	-	-	-
Q2 2007	-	-	-
Q3 2007	-	-	-
Q4 2007	-	-	-
Q1 2008	-	-	-
Q2 2008	-	-	-
Q3 2008	-	-	-
Q4 2008	-	-	-
Q1 2009	-	-	-
Q2 2009	-	-	-
Q3 2009	14.20	14.20	3.31
Q4 2009	14.31	14.31	3.19
Q1 2010	13.68	13.68	3.02
Q2 2010	14.64	14.64	3.19
Q3 2010	14.75	14.75	3.11
Q4 2010	15.18	15.18	3.15
Q1 2011	13.52	13.52	2.77
Q2 2011	16.08	16.08	3.50
Q3 2011	13.29	13.29	2.96
Q4 2011	15.92	15.92	3.53
Q1 2012	16.83	16.83	3.66
Q2 2012	13.89	13.89	3.27
Q3 2012	15.57	15.57	3.53
Q4 2012	15.66	15.66	3.52
Q1 2013	18.00	18.00	3.92
Q2 2013	18.62	18.62	4.32
Q3 2013	21.21	21.21	4.88
Q4 2013	22.86	22.86	5.18
Q1 2014	21.78	21.78	4.75
Q2 2014	24.19	24.19	5.66
Q3 2014	26.21	28.82	6.43
Q4 2014	25.71	28.55	6.01

Period	P/E	Adjusted P/E	Price/book
2005	-	-	-
2006	-	-	-
2007	-	-	-
2008	-	-	-
2009	14.31	14.31	3.19
2010	15.18	15.18	3.15
2011	15.92	15.92	3.53
2012	15.66	15.66	3.52
2013	22.86	22.86	5.18
2014	25.71	28.55	6.01

Business Segments (Million)

Compared With The

Period	Medical Services	Pharmaceutical Products	Administration Fees
Q1 2008	86.60	26.81	0.43
Q2 2008	91.71	26.38	0.40
Q3 2008	84.21	20.23	0.47
Q4 2008	84.07	31.65	1.61
Q1 2009	94.61	29.63	0.36
Q2 2009	105.22	28.44	6.97
Q3 2009	92.73	26.15	(3.67)
Q4 2009	103.72	33.04	0.40
Q1 2010	109.41	32.47	1.92
Q2 2010	114.73	34.05	-
Q3 2010	102.85	31.87	-
Q4 2010	118.91	41.29	-
Q1 2011	129.63	37.19	-
Q2 2011	128.04	36.89	-
Q3 2011	123.09	33.84	-
Q4 2011	149.24	40.52	-
Q1 2012	155.38	40.19	-
Q2 2012	159.24	41.38	-
Q3 2012	149.51	37.77	-
Q4 2012	168.11	44.93	-
Q1 2013	177.18	42.05	-
Q2 2013	186.71	42.02	-
Q3 2013	172.61	39.02	-
Q4 2013	197.43	45.21	-
Q1 2014	196.67	46.87	-
Q2 2014	198.14	46.10	-
Q3 2014	186.70	43.78	-
Q4 2014	137.05	48.48	-

Period	Medical Services	Pharmaceutical Products	Administration Fees
2005	218.74	46.93	1.72
2006	275.14	66.36	1.42
2007	309.44	88.92	2.32
2008	346.58	105.06	2.91
2009	396.28	117.25	4.07
2010	445.90	139.68	1.92
2011	530.00	148.44	-
2012	632.24	164.27	-
2013	733.93	168.30	-
2014	718.55	185.23	-

Analysts Estimates (Million)

Item	Q4 2014 (e)	Q4 2014 (a)	Change‬
Average	49.40	50.75	2.73 %

Estimates vs Actual (Million)

Item	Q4 2014 (e)	Q4 2014 (a)	Change
OSOOL AND BAKHEET	49.40	50.75	2.7 %

Financial Ratios

	Current
Market Cap (M Riyal)	18,880.00
Enterprise Value (EV) (M)	19,700.65
Shares Outstanding ((M))	200.00
EPS ( Riyal) (TTM)	3.29
Book Value (BV) ( Riyal)	17.66
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	28.69
P/E (TTM)	28.69
Price/book	5.34
Return on Average Assets (%) (TTM)	13.0
Return on Average Equity (%) (TTM)	19.9

Mouwasat Medical Services Co. (MOUWASAT)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Mouwasat’s 2014 net profit up 19% to SAR 240.1 mln

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2014 Q4

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Share Price

Mouwasat Medical Services Co. (MOUWASAT)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

×

Mouwasat’s 2014 net profit up 19% to SAR 240.1 mln

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q4 2014

Revenue by Business Segment (Latest) 2014 Q4

Analysts Estimates (Million)

Analysts Estimates (Million)

Estimates vs Actual (Million)

Estimates Accuracy

Financial Ratios

Share Price

Mouwasat Medical Services Co. (MOUWASAT)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)